Dr. James McCaffrey from Microsoft Research presents a complete end-to-end demonstration of the linear support vector ...

Most executives still believe the hardest part of enterprise AI is building the model. It’s not. The real challenge begins ...

Background Current treatments with tyrosine kinase inhibitors and immune checkpoint inhibitors have limited efficacy for ...